AG
STIM icon

Advisor Group’s Neuronetics STIM Stock Holding History

Advisor Group’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6K Sell
1,390
-500
-26% -$3.11K ﹤0.01% 4598
2019
Q3 		$16K Hold
1,890
– – ﹤0.01% 4099
2019
Q2 		$24K Buy
1,890
+250
+15% +$3.53K ﹤0.01% 3874
2019
Q1 		$25K Buy
1,640
+250
+18% +$4.14K ﹤0.01% 3866
2018
Q4 		$27K Buy
+1,390
New +$30.5K ﹤0.01% 3618

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor Group's STIM Position: Q4 2019 in Review

Advisor Group reduced its Neuronetics (STIM) stake by 26% in Q4 2019, selling an estimated $3.11K and leaving 1,390 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4598.

Advisor Group first reported a position in STIM in Q4 2018 and has held it in 5 quarters since. The position peaked at $27K in Q4 2018. 68 funds tracked by Wall St. Rank hold STIM as of Q4 2019.

  • Advisor Group held 1,390 shares of Neuronetics worth $6K as of Q4 2019.
  • Advisor Group sold 500 Neuronetics shares in Q4 2019, an estimated $3.11K.
  • Neuronetics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4598 holding.
  • Advisor Group first reported a position in Neuronetics in Q4 2018 and has held it in 5 quarters since.
  • Advisor Group's Neuronetics position peaked at $27K in Q4 2018.
  • 68 funds tracked by Wall St. Rank held Neuronetics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.